2011 Volume 13 Issue 1 Published:
  

  • Select all
    |

    论著

  • 论著
    Cui Weihua;Tan Hong;Han Ruquan;Li Yanping;Li Shuren
    2011, 13(1): 1-6.
    Abstract ( ) PDF ( )
    Objective: To study the effect of lowdose lidocaine on the efficiency of induction and maintenance of propofol anesthesia. Methods: Forty ASA physical status ⅠorⅡpatients aged 18-65 years, who were scheduled to undergo elective thoracotomy under general anesthesia with propofol, were enrolled in the study and randomly divided into the following two groups by using ballot method: the lidocaine group and the control group (20 patients in each group). The administration sequence during the anesthetic induction and maintenance in the two groups were as follows: (1) the patients received an IV infusion of midazolam maleate 0.03 mg/kg; (2) the patients in the lidocaine group were initially administered an IV infusion of lidocaine 1 mg/kg, followed by a continuous IV infusion of lidocaine 33 μg·kg-1·min-1, and the patients in the control group were administered the same volume of 0.9% sodium chloride at the same rate; (3) the patients received an IV infusion of remifentanil 1 μg/kg, followed by a continuous IV infusion of remifentanil 0.2 μg·kg-1·min-1; (4) an IV infusion of propofol was given, the initial target propofol blood concentration for induction was 1 ml/L, and then increased in steps of 0.3 mg/L at a time, achieving a stable bispectral index (BIS) of 4060; (5) rocuronium was given intravenously 0.6 mg/kg after the patients lost consciousness. The differences in BIS, heart rate, invasive arterial pressure(IAP), target propofol blood concentration, effect compartment propofol concentration, pharyngonasal temperature, doses of atropine or ephedrine or nitroglycerin, adverse reactions and complications in the two groups at the different time points during intraoperative period were monitored and compared. The patients’lidocaine blood concentrations were monitored. Results: The lidocaine group comprised 13 males and 7 females with average age of (54±9)years. The control group comprised 13 males and 7 females with average age of (51±1)years. There were no statistically significant differences in baseline patient characteristics, doses of atropine or ephedrine or nitroglycerin, BIS, IAP, pharyngonasal temperature, and the incidence of adverse reaction between the two groups. There were no serious adverse reactions and complications in the two groups. The target propofol blood concentration and effect compartment propofol blood concentration in the lidocaine and control groups at the different time points were respectively compared as follows: at the time of tracheal intubation, the concentrations were(1.9±0.4) mg/L vs(2.4±0.4) mg/L and (1.2±0.4) mg/L vs (1.6±0.4) mg/L,respectively;at the time of organ resection, the concentrations were (2.0±0.5) mg/L vs (2.7±0.7) mg/L and (2.0±0.5) mg/L vs (2.7±0.7) mg/L, respectively;at the time of chest cavity shut, the concentrations were(1.7±0.4) mg/L vs(2.2±0.7) mg/L and (1.8±0.4) mg/L vs (2.3±0.7) mg/L, respectively; at the time of tracheal extubation, the concentrations were(0.8±0.2) mg/L vs(0.9±0.2) mg/L and (0.9±0.2) mg/L vs(1.0±0.3) mg/L, respectively. The differences were statistically significant (all P<0.05). The patients’ lidocaine blood concentration 30, 120, 240 minutes after anesthetic induction and after surgery completion were(2.24±0.53), (2.20±0.42), (2.45±0.73) and (2.31±0.75) mg/L, respectively, and they were lower than a toxic blood concentration of lidocaine (8.0 mg/L). Conclusion: The low-dose lidocaine can increase the efficiency of induction and maintenance of propofol anesthesia.
  • 论著
    Fu Shihui;Zhu Bing;Wang Hao;Wang Liang;Liu Yuan;Ye Ping;Luo Leiming
    2011, 13(1): 7-6.
    Abstract ( ) PDF ( )
    Objective: To explore the efficacy and safety of recombinant human brain natriuretic peptide (rhBNP) in patients with advanced age and acute decompensated heart failure. Methods: A randomized controlled trials was performed. From January 2008 to December 2010, 80 hospitalized patients with advanced age and acute decompensated heart failure in Chinese PLA General Hospital were enrolled in this study. They were randomly divided into the conventional treatment group (conventional group) and the conventional treatment plus rhBNP group (rhBNP group) by using ballot method. There were 40 patients in each group. The patients in the conventional group received the conventional treatment for acute decompensated heart failure, and patients in the rhBNP group received the conventional treatment plus a continuous IV infusion of rhBNP 0.5-1.0 mg in 50 ml of normal saline via a pump at a rate of 0.007 5-0.015 0 μg·kg-1·min-1 for 10-15 hours once daily. The course of treatment was 13 days. The scores of dyspnea and edema, net water loss volume, heart rate, blood pressure, and serum creatinine level in the two groups before and after treatment (on days 4, 8, and 14) were compared. Results: The conventional group comprised 37 males and 3 females with mean age of (88±4)years; The rhBNP group comprised 38 males and 2 females with mean age of (86±5) years. There was no statistically significant differences in the baseline clinical characteristics and the drugs used for the treatment of heart failure between the two groups before treatment. On day 4, there was no statistically significant difference in the scores of dyspnea between the two groups (P>0.05). On days 4 and 8, the scores of dyspnea in the rhBNP group were significantly lower than those in the conventional group (all P<0.05). On days 4, 8 and 14, the scores of edema in the rhBNP group were significantly lower than those in the conventional group (all P<0.05). On days 4, 8 and 14, the net water lose volume in the rhBNP group was significantly greater than those in the conventional group [263.5 (-793, 2184)ml vs -129.0(-1249, 3636) ml,239.5 (-754,1370)ml vs -29.5 (-1364, 2242) ml, and 386.5 (-564,1490)ml vs 71.0 (-2274,1660) ml, respectively; all P<0.05]. On days 4, 8 and 14, there were no statistically significant differences in blood pressure and serum creatinine level between the two groups(all P>0.05). On days 4 and 8, the heart rates in the rhBNP group were significantly lower than those in the conventional group [(73±13)beats/min vs (81±17)beats/min and (70±10)beats/min vs (79±16)beats/min, respectively; all P<0.05]. Conclusion: The conventional treatment plus rhBNP has better efficacy and safety in treating patients with advanced age and acute decompensated heart failure.
  • 论著
    Zhang Wei;Wan Suigui;Wang Xi;Sun Xuejing;Liu Congyan;Liu Yan;He Jingjuan;Zhao Hong;Xu Juan
    2011, 13(1): 13-4.
    Abstract ( ) PDF ( )
    Objective: To explore the efficacy and safety of ciclosporine in treatment of myelodysplastic syndrome (MDS) with erythroid hypoplasia. Methods: Five patients were diagnosed with MDS by routine blood tests ,bone marrow morphology, flow cytometry and karyotype analysis. All patients were treated with ciclosporine 100-200 mg/d. The efficacy was assessed according to the modified criteria of the International Working Group (2006), and adverse reactions were evaluated with Common Terminology Criteria for Adverse Events V3.0. Results: Five patients comprised 3 males and 2 females, aged 47-71 years with median age of 56 years. All patients achieved hematologic improvementerythroid (HI-E) after 1 month of ciclosporine treatment. The hemoglobin levels in 4 patients were 94-146 g/L with average level of 118 g/L after 3 months of treatment ( 1 patient was treated with ciclosporine for only 1 month). The hemoglobin levels in 3 patients were stable. The hemoglobin level in another patient decreased to the level before treatment because ciclosporine was withdraw by himself after 3 months of treatment, and returned gradually to the normal after he took ciclosporine again. Six adverse reactions occurred in 5 patients including gingival hyperplasia (n=3), polytrichia (n=2), and skin pigmentation (n=1), but there was no grade ≥3 adverse reactions Conclusion: Preliminary study results show that ciclosporine is effective and safe in treatment of MDS with erythroid hypoplasia.
  • 安全用药

  • 安全用药
    Zeng Lingling;Zhou Guiqin
    2011, 13(1): 17-4.
    Abstract ( ) PDF ( )
    Drug-induced liver injury(DILI) is one of the common adverse drug reactions. Over 1100 drugs and related substances are associated with DILI. However, there is no specific diagnostic marker to DILI so far. This paper introduces and discusses some main diagnostic criterias in order to be helpful for diagnosis of DILI in clinical practice.
  • 安全用药
    Zhou Xiping;Li Hong
    2011, 13(1): 21-6.
    Abstract ( ) PDF ( )
    Iodinated contrast media (ICM) are the most commonly used drugs in diagnostic visualisation technique. ICM may be classified as ionic and nonionic according to their chemical structure or highosmolar, lowosmolar, and isoosmolar according to their osmolality. ICM are generally considered to be relatively safe, but serious adverse reactions may occur, such as severe immediate hypersensitivity reactions. Severe immediate hypersensitivity reactions may lead to angioedema, unconsciousness, profound hypotension, arrhythmias, respiratory arrest and cardiac arrest, and so on. The incidence rates of severe immediate hypersensitivity reactions to ionic and nonionic ICM are 0.1%- 0.4% and 0.02%- 0.04%,respectively. The most significant risk factor for an immediate hypersensitivity reaction is a history of a hypersensitivity reaction to contrast media. Other risk factors are the history of asthma and allergic history to drug or food, and so on. The mechanism of ICM-induced immediate hypersensitivity reactions may be related to histamine release from basophil and mast cells. Histamine release might be due to a direct membrane effect associated with the solution osmolarity or the chemical structure of ICM, an activation of the complement system, as well as the formation of bradykinin and the activation of antigenantibody reactions mediated by IgE. The preventive and therapeutic measures are as follows: (1) application of low-osmolar or iso-osmolar and nonionic ICM as far as possible; (2) the skin test and the premedication such as glucocorticoid and antihistamine to the patients with risk factors should be recommended; (3) the patients with moderate or severe hypersensitivity reactions to ICM should receive the symptomatic and supportive treatments.
  • 安全用药
    Zhou Jianqiu;Mei Dan
    2011, 13(1): 27-5.
    Abstract ( ) PDF ( )

    Pharmaceutical packaging materials refer to packaging materials and containers which come into direct contact with medicines. Present major pharmaceutical packaging materials include the following four categories: glass, rubber, plastic, and metal materials. Pharmaceutical packaging materials might interact with the medicines which are packed. Some pharmaceutical packaging materials could absorb the active ingredient in medicines, thus decreasing their curative effects, and some may release hazardous substances, thus harming the body tissues. Therefore, quality control of pharmaceutical packaging materials should be strengthened; appropriate pharmaceutical packaging materials should be selected according to characteristics of medicines; and attention should be paid to drug safety problems associated with pharmaceutical packaging materials.

  • 安全用药
    Lou Ying;Li Yishi
    2011, 13(1): 32-6.
    Abstract ( ) PDF ( )
    Warfarin is a coumarin anticoagulant widely used in the treatment and prevention of thromboembolic disorders. Warfarin has narrow therapeutic window and individual differences in dose, and hemorrhagic complications may occur in clinical use of warfarin. Recent studies indicate that the individual difference in warfarin dose is associated with gene polymorphisms influencing metabolism and action of warfarin such as CYP2C9,VKORC, and so on. The paper reviews the progress of the pharmacogenomics of warfarin in order to provide a reference for rational use of warfarin in clinical practice.
  • 中毒救治

  • 中毒救治
    Deng Zhen;Xiang Yunjie;Shen Qing
    2011, 13(1): 38-2.
    Abstract ( ) PDF ( )
    An 8monthold male infant suffered from pneumonia and treatment with salbutamol sulfate 0.8 mg (1/3 tablet) thrice daily was planned. However, because of his parents’misunderstanding, the infant was given a single dose of salbutamol sulfate 7.2 mg (3 tablets). One hour later, the infant presented with nausea, vomiting, and diarrhea with 6 watery stools. A routine stool examination showed watery stool with fat globules (++). Salbutamol sulfate was withdrawn. Cefoperazone sodium/sulbactam sodium, asarone, and sodium bicarbonate were given; in addition, he received an enema and antidiarrheal treatment. As a result, his condition was brought under control.
    KEY WORDSsalbutamol sulfate; diarrhea
  • 病例报告

  • 病例报告
    Li Lihua;Wei Hua;Song Xiaodan
    2011, 13(1): 45-1.
    Abstract ( ) PDF ( )
    Two patients, a 58-year-old man and a 49-year-old woman, received metronidazole 0.4 g thrice daily for prevention and treatment of oral infection. They presented with gross hematuria on days 2 and 3 after drug administration, respectively, followed by lumbago, urgency of urination, urinary frequency, painful urination, and other symptoms. Routine urine tests revealed RBC(++)in the male patient and numerous RBC in the female patient. Metronidazole was discontinued and switched to combination treatment with cefalexin and erythromycin ethylsuccinate. Their symptoms improved gradually and then disappeared.
  • 病例报告
    Shi Lijin;Gao Qin;Xu Min;Wang Guoqing;Huang Lunfeng
    2011, 13(1): 46-1.
    Abstract ( ) PDF ( )
    A 43-year-old woman with bronchiectasis complicated by infection received an IV infusion of ceftezole sodium 2.0 g dissolved in 0.9% sodium chloride 250 ml, followed by an IV infusion of clindamycin 1.2 g dissolved in 10% glucose 500 ml 5 hours later. About 20 minutes after the infusion started, the patient experienced abdominal pain, repeated vomiting, and gross hematuria. Clindamycin was discontinued immediately and she was given IM diclofenac sodium 50 mg and IM cimetidine 200 mg. Later, her abdominal pain alleviated. She failed to urinate 3 hours after the administration of clindamycin until the next morning, and then generalized edema occurred. Renal function tests showed the following values: blood urea nitrogen 17.6 mmol/L, serum creatinine 544 μmol/L. She was diagnosed with clindamycininduced acute renal failure. On days 3 and 6 after admission she received hemodialysis, and then her urine output gradually returned to normal range. Her blood urea nitrogen and serum creatinine levels were 4.3 mmol/L and 65 μmol/L, respectively. After administration of an infusion of ceftezole sodium 2.0 g/d for treatment infection, the patient’s symptom of cough was relieved and purulent sputum disappeared. On day 7, she was discharged.
  • 病例报告
    Sun Suxin
    2011, 13(1): 47-1.
    Abstract ( ) PDF ( )
    A 76yearold male patient with erysipelas received an IV infusion of amoxicillin/sulbactam 2.25 g in 0.9% sodium chloride 100 ml twice daily and an IV infusion of 0.4% tinidazole 100 ml once daily. Six days later, his routine blood tests revealed the following results: WBC count 1.86×109/L with neutrophils 0.21, lymphocytes 0.55, and monocytes 0.23, and neutrophil count 039×109/L. Amoxicillin/sulbactam and tinidazole were withdrawn immediately and he received symptomatic treatment. Three days after drug discontinuation, routine blood tests showed a WBC count of 3.20×109/L with neutrophils 0.32, lymphocytes 0.54, and monocytes 0.12, and a neutrophil count of 1.04×109/L.
  • 病例报告
    Zhang Na
    2011, 13(1): 48-1.
    Abstract ( ) PDF ( )
    A 75-year-old man received an IV infusion of ambroxol hydrochloride glucose injection 50 ml (containing ambroxol hydrochloride 30 mg and glucose 2.5 g) for pulmonary infection. About 30 minutes later, the patient abruptly experienced chest distress, cold sweat, nausea, and dizziness. Physical examination showed a blood pressure of 40/0 mm Hg, cyanosis, pale face, cold extremities, and confusion. The intravenous infusion was stopped immediately. He underwent electrocardiogram monitoring and received oxygen inhalation therapy, dexamethasone, promethazine, and dopamine. His blood pressure became stable and was 130/70 mm Hg 4 hours later. His other vital signs were normal, and his symptoms disappeared. During a twoweek hospitalization, intravenous infusion of ambroxol hydrochloride was not readministered and similar symptoms did not recur.
  • 病例报告
    Liao Shumei;Nan Ling
    2011, 13(1): 49-1.
    Abstract ( ) PDF ( )
    A 71yearold man with knee osteoarthritis was given an intraarticular injection of sodium hyaluronate 20 mg in his right knee. The patient did not present with obvious discomfort after the first injection. Six days later, he received the second intraarticular injection of sodium hyaluronate 20 mg. About 5 hours after the second injection, he experienced chills, palpitation, and dyspnea. At the same time, his blood pressure was 96/60 mm Hg. He received oxygen inhalation therapy and symptomatic treatment. One hour later, his symptoms relieved and blood pressure was 105/70 mm Hg. During hospitalization, sodium hyaluronate was not given again and the abovementioned adverse reactions did not recur any more. He was discharged after two weeks of hospitalization.
  • 病例报告
    Liu Xiaodong;Sun Hao;Liu Limin;Zhao Limei
    2011, 13(1): 50-1.
    Abstract ( ) PDF ( )
    A 44yearold man received cefotiam, compound mannitol, followed by an IV infusion of oxiracetam 4.0 g dissolved in 5% glucose 250 ml after undergoing surgery for intraspinal neurilemma. About 15 minutes after oxiracetam infusion start, the patient experienced convulsion, diaphoresis accompanied by facial and peripheral cyanosis. Oxiracetam was discontinued and he was given mask oxygen. ECG monitoring revealed a blood pressure of 90/60 mm Hg and a heart rate of 120 beats/min. Adrenaline 1 mg was given by IV push, and then a rapid IV infusion of 0.9% sodium chloride injection 500 ml was administered. Ten minutes later, his blood pressure decreased to 80/50 mm Hg and his oxygen saturation was 0.90. He received an IV push of adrenaline 1 mg and dexamethasone 5 mg again. Twenty minutes later, the patient’s convulsions disappeared and his blood pressure increased to 100/75 mm Hg.
  • 病例报告
    Chen Xinzheng;Li Xia
    2011, 13(1): 51-2.
    Abstract ( ) PDF ( )
    Two men with chronic hepatitis B, aged 32 and 43 years, developed tubular injury and decreased serum phosphorus level after receiving oral adefovir dipivoxil 10 mg once daily. In patient 1, the laboratory tests revealed the following values: SCr 158 μmol/L,BUN 4.04 mmol/L,serum phosphorus 0.67 mmol/L, and creatinine clearance rate 47.6 ml/min 236 weeks after the start of treatment. And in patient 2, the laboratory tests showed the following levels: SCr 141 μmol/L,BUN 6.59 mmol/L,serum phosphorus 0.68 mmol/L, and creatinine clearance rate 48.7 ml/min 65 weeks after the start of treatment. However, their routine urine tests and urinary volumes were within normal range, and there was no generalized edema. The dosage regimen of adefovir dipivoxil was changed to 10 mg once every other day according to the creatinine clearance rate. Twelve weeks later, their SCr and BUN values decreased or returned to normal.
  • 病例报告
    Nie Xina;Pan Qib
    2011, 13(1): 52-2.
    Abstract ( ) PDF ( )
    A 62yearold woman with type 2 diabetic mellitus was hospitalized with relapsing hypoglycemia. Routine blood tests showed that her eosinophil count and percentage were 1.72×109/L and 25.4%, respectively. Eosinophilia was diagnosed. A review of her medical history revealed that she had received SC aldesleukin 200 million units once every other day for 4 months and more after undergoing radical operation for cancer of the gastric antrum. During the treatment of aldesleukin, her eosinophil counts and percentages were gradually increasing as follows: on day 3, 0.02×109/L and 2.3%; on day 11, 0.33×109/L and 7.4%; on day 26, 3.07×109/L and 38.7%; on day 34, 4.21×109/L and 47.1%. Eosinophilia was considered to be related to aldesleukin. Aldesleukin was discontinued and, two weeks later, her eosinophil count returned to normal range.
  • 病例报告
    Li Jing;Zhao Min
    2011, 13(1): 54-2.
    Abstract ( ) PDF ( )
    A 71yearold woman received an IV infusion of adenosine cyclophosphate 40 mg in 0.9% sodium chloride 250 ml for her hyperthyroid heart disease. About five minutes after the infusion started, she experienced severe lumbago and palpitation, followed by bilateral palpebral oedema, chest distress and vomiting 30 minutes later. Her blood pressure was 180-190/100-105 mm Hg, and moist rales were heard in the lower lungs. Renal function tests showed the following values: occult blood (+++), protein (+++), and 1-2 RBC/high power field. Adenosine cyclophosphate was discontinued immediately and she received oxygen inhalation,dexamethasone, furosemide, omeprazole, and nifedipine. About two hours later, the patient urinated >1000 ml. She had a blood pressure of 159/65 mm Hg, an oxygen saturation 0.97, and a heart rate of 85 beats/min. Moist rales in both lungs reduced significantly. Three days later, the patient basically returned to normal.
  • 病例报告
    Wang Yuping;Lin Hong
    2011, 13(1): 55-2.
    Abstract ( ) PDF ( )
    A 9monthold male infant received an IV infusion of ceftriaxone sodium for fever and cough, and then his temperature normalized. However, he developed facial pale, cry and noisy, and loss of appetite. Two days later, ceftriaxone sodium was replaced with IM penicillin, and the infant experienced lowgrade fever again. A further two days later, routine blood tests revealed the following levels: Hb 67 g/L, RBC 2.95×1012/L, WBC 22.16×109/L with neutrophils 0.30,lymphocytes 0.60,monocytes 0.07,and abnormal lymphocytes 0.03. He was administered an IV infusion of ceftriaxone sodium 0.9 g dissolved in 100 ml of 10% glucose, followed by intravenous ambroxol 15 mg via Murphy’s dropper. After receiving the infusion about 70 ml, the baby suddenly presented with facial pale, cry and noisy, brownish red urine, short of breath. Laboratory testing showed the following values: Hb 27 g/L, RBC 1.75×1012/L with reticulocytes 0.045, Coomb’s C31∶4, urine occult blood (+++), and urinary RBC 2-8 cells per high power field. Ceftriaxone sodium was stopped immediately. Meanwhile he received RBC transfusions and methylprednisolone pulse therapy. On day 6, routine blood tests showed a Hb level of 111 g/L and a RBC count of 3.83×1012/L. His condition improved.
  • 病例报告
    Hou Xiaoping;Miao Jingli
    2011, 13(1): 56-3.
    Abstract ( ) PDF ( )
    A 91yearold man with coronary artery disease received venlafaxine 150 mg/day for treatment of anxiety/depression for about one year. Because of his aggravated mental symptoms, the withdrawal of venlafaxine and the administration of other drugs were planned. Subsequently, venlafaxine was decreased to 75 mg/day, and then discontinued 1 day. The next day morning, the patient suddenly developed unconsciousness and, 10 minutes later, he regained consciousness. His blood pressure was 50/30 mm Hg. He was treated with dopamine. The second day, acute myocardial infarction was confirmed by ECG, and venlafaxine withdrawal syndrome was diagnosed. The patient was given aspirin, clopidogrel, nitroglycerin, and quetiapine. Later, the patient markedly improved and, after 20 days of hospitalization, he was discharged.
  • 病例报告
    He Yan;Xin Huawen;Li Qing
    2011, 13(1): 58-2.
    Abstract ( ) PDF ( )
    A 63yearold woman selfadministered one capsule of Move Free Advanced twice a day for cervical spondylosis and periarthritis of the shoulder. A total of 99 capsules was taken, during the administration period of one month and more, the patient developed yellowish skin and dark urine, accompanied by fatigue, nausea, and loss of appetite. Laboratory tests showed the following: ALT 322 U/L, AST 1108 U/L, TBil 133 μmol/L, and DBil 85 μmol/L. Move Free Advanced was discontinued and liverprotective treatment was given. However, her jaundice remained and she was hospitalized. The patient received entericcoated adenosyl methionine for 20 days. Her liver function tests revealed the following values: ALT 102 U/L, AST 89 U/L, TBil 604 μmol/L, and DBil 271 μmol/L. Severe druginduced liver damage was diagnosed. She received plasma exchange, followed by L-ornithine-L-aspartate, ursodeoxycholic acid, and albumin. Five months later, repeat liver function tests showed the following levels: ALT 21 U/L, AST 50 U/L, TBil 134 μmol/L, and DBil 70 μmol/L, and the patient’s condition improved markedly.
  • 病例报告
    Huang Jiantong;Li Peilan
    2011, 13(1): 59-2.
    Abstract ( ) PDF ( )
    A 53yearold male patient with pharyngitis was given an IV infusion of clindamycin 600 mg dissolved in 0.9% sodium chloride 250 ml. After infusion completion, the patient developed a coma and unresponsiveness to verbal stimuli. His respiratory rate was 12 breaths/min and his pupils showed no light reflex. He received oxygen inhalation therapy and fluid supplement and, one hour later, he remained in a deep coma. The patient was treated with mannitol, furosemide,naloxone,puerarin and sodium ozagrel by intravenous infusions, respectively. After about 12 hours of treatment, the patient regained consciousness and, after about 15 hours of treatment, he suddenly presented with mania. IM haloperidol 5 mg was given. After about 20 hours of treatment, his mental condition basically returned to normal.
  • 病例报告
    Yu Junling;Feng Aiqiao;Zhang Yujuan
    2011, 13(1): 60-2.
    Abstract ( ) PDF ( )
    A 35yearold male patient with chronic hepatitis C received IM peginterferon alfa-2b 2 million units once weekly. Four months later, the patient experienced auditory hallucination, delusion, and mild personality changes. Subsequently, his symptoms gradually aggravated. One week later, he presented with delusion of persecution, thought incoherence, emotion discord, irritability, and insight disorder. Peginterferon alfa-2b was withdrawn, and he received symptomatic treatment with olanzapine. One week after therapy, his symptoms improved and, two weeks after therapy, he was discharged, and continued taking olanzapine for one week, and then the drug was stopped by himself. The above-mentioned psychiatric symptoms did not recur during a half year of follow-up.
  • 病例报告
    Liu Jianfeng;Liu Ran;Tu Xiaojuan
    2011, 13(1): 61-2.
    Abstract ( ) PDF ( )
    A 40yearold man who had normal thyroid function and nodular goiter developed palpitation and hyperhidrosis on day 10 while he was receiving oral compound iodine solution 10 drops thrice daily before surgery. The thyroid function tests showed the following levels: triiodothyronine 3.21 nmol/L, thyroxine 142.10 nmol/L, free triiodothyronine 8.80 pmol/L, free thyroxine 28.18 pmol/L, thyroidstimulating hormone 0.03 mU/L. The compound iodine solution was discontinued immediately and oral methimazole 10 mg was given twice daily. After one month of treatment, his thyroid function became normal, and then he underwent surgical treatment.